All News

Four generic manufacturers (Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals, and Torrent Pharmaceuticals) received the go-ahead April 28 to market their generic versions for Abilify for the treatment of schizophrenia and bipolar disorder.

As part of a pilot program, some dentists and dental hygienists in Canada will be providing free oral-cancer screenings at various London Drugs locations starting this month.

Beginning in July, California hospitals are required to have an antimicrobial stewardship program (ASP) in place to evaluate the judicious use of antibiotics.

FDA approved Sandoz’s generic version of Copaxone (glatiramer acetate injection) known as Glatopa, making it the first generic version of the drug available for patients with relapsing forms of multiple sclerosis.

The National Association of Chain Drug Stores is applauding the U.S. House of Representatives’ recent passage of a bill designed to curb prescription drug abuse while protecting patient access to controlled substances.

Children’s hospitals with formal antibiotic stewardship programs helped reduce antibiotic use significantly following the 2007 release of guidelines for developing these programs, according to a report published in Pediatrics.

The American Society of Health-System Pharmacists has announced the slate of candidates running for president, board of directors, and to chair its House of Delegates.

The Office of Inspector General of the U.S. Department of Health & Human Services (HHS) recently announced it would investigate price increases for generic drugs in the Medicaid drug rebate program.

The pharmaceutical and healthcare industry is lauding the FDA’s approval of the first biosimilar product this year, noting that the drugs could save the U.S. healthcare system billions of dollars.

California pharmacist Afrouz Nikmanesh’s class-action lawsuit against Walmart recently suffered a major blow with the dismissal of most of her allegations against the giant retailer.

Yet another study has reinforced what several others have also documented - pharmacist involvement in patient care improves medication adherence and healthcare outcomes.

Pharmacists swear an oath to do no harm. But what about patients? Should they be responsible for their behavior toward us?

Helping consumers better understand over-the-counter medications they are taking as well as freeing up pharmacists to consult with patients are the primary goals behind a new smartphone application.

New Rx, indication, generics, and OTC.

Pharmacists who lose touch with the core of their professional identities abandon much more than just activities and functions.

The new CPE series that begins this month will focus on treatment and management of respiratory diseases.

The probable is not pharmacist glut. The problem is underused pharmacists.

This blackbird is a good omen.

A word from the Honest Apothecary: Guest columnist Jason Poquette spells out what transitions of care actually involve.

Retail pharmacists are ideally situated to perform MTM through collaborative agreements with physicians, and some are making it happen.

Cost of treatment often forces aging patients on limited incomes to choose between paying for medications or for food and rent.

The CDC committee voted on 2015 protocols for use of meningitis, influenza, and HPV vaccines at its February meeting.

Key trends point to a collaboration between pharmacies and healthcare stakeholders that will shape better delivery of patient education, adherence support, and financial assistance.

For women building pharmacy careers, going it alone is not the most likely recipe for success.

A new dantrolene sodium suspension with improved properties offers an advantage over the older formulations- and a much higher price tag.

Auryxia, an iron-based phosphate binder, was approved September 5, 2014.

Oral anticoagulation therapy is the treatment of choice for clot prevention in hemodialysis patients, despite contradictory efficacy data.

Tips for managing pharmacy and business data BEFORE you find yourself caught up in litigation.